Compare JBGS & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JBGS | CBLL |
|---|---|---|
| Founded | 2016 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | |
| Sector | Real Estate | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 823.7M | 726.2M |
| IPO Year | 2017 | 2024 |
| Metric | JBGS | CBLL |
|---|---|---|
| Price | $12.29 | $23.44 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $15.00 | ★ $23.20 |
| AVG Volume (30 Days) | ★ 897.1K | 397.3K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | ★ 4.69% | N/A |
| EPS Growth | N/A | ★ 56.93 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $498,598,000.00 | $89,063,000.00 |
| Revenue This Year | N/A | $29.57 |
| Revenue Next Year | N/A | $28.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 36.09 |
| 52 Week Low | $10.77 | $10.85 |
| 52 Week High | $24.30 | $25.33 |
| Indicator | JBGS | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 65.90 |
| Support Level | $10.77 | $16.70 |
| Resistance Level | $15.17 | $24.64 |
| Average True Range (ATR) | 0.43 | 1.06 |
| MACD | 0.17 | 0.15 |
| Stochastic Oscillator | 86.00 | 74.33 |
JBG SMITH Properties is a real estate investment trust based in the United States. It owns, operates, invests in, and develops real estate assets concentrated in amenity-rich, metro-served submarkets in and around Washington, DC. In addition, the company also provides fee-based real estate services to legacy funds through its third-party real estate services business. The operating segments of the company are commercial, multifamily, and third-party real estate services. It generates maximum revenue from the commercial segment.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.